Related Experiment Video

Updated: Jul 13, 2026

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts
07:18

Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts

Published on: June 13, 2019

Identification and characterization of a novel protein ISOC2 that interacts with p16INK4a

Xiaoyi Huang1, Zhongcheng Shi, Wei Wang

  • 1Department of Medical Genetics, Harbin Medical University, Baojian Road, Harbin 150081, China.

Biochemical and Biophysical Research Communications
|July 31, 2007
PubMed

Insights

Researchers identified isochorismatase domain containing 2 (ISOC2) as a novel protein interacting with the tumor suppressor p16(INK4a). Overexpressed ISOC2 inhibits p16(INK4a) expression, suggesting a role in tumor development.

Area of Science:

  • Molecular Biology
  • Oncology
  • Protein Interactions

Background:

  • p16(INK4a) is a crucial tumor suppressor involved in cell proliferation and tumorigenesis.
  • Identifying proteins associated with p16(INK4a) is vital for understanding its regulatory mechanisms.

Purpose of the Study:

  • To identify novel proteins that interact with the tumor suppressor p16(INK4a).
  • To investigate the functional consequences of the interaction between p16(INK4a) and a newly identified protein, ISOC2.

Main Methods:

  • Yeast two-hybrid assay for protein interaction screening.
  • In vitro pull-down assays and in vivo co-immunoprecipitation for interaction verification.
  • Confocal microscopy for co-localization studies.

Main Results:

  • A novel protein, isochorismatase domain containing 2 (ISOC2), was identified as interacting with p16(INK4a).
  • ISOC2 and p16(INK4a) were confirmed to interact physically and co-localize within cells.
  • Overexpression of ISOC2 inhibited p16(INK4a) expression in a dose-dependent manner.

Conclusions:

  • ISOC2 is a novel functional protein that binds to and co-localizes with the tumor suppressor p16(INK4a).
  • ISOC2's ability to inhibit p16(INK4a) suggests a potential role in tumor development through modulation of p16(INK4a) activity.

More Related Videos

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry08:07

Identification of Inositol Phosphate or Phosphoinositide Interacting Proteins by Affinity Chromatography Coupled to Western Blot or Mass Spectrometry

Published on: July 26, 2019

A Protein Preparation Method for the High-throughput Identification of Proteins Interacting with a Nuclear Cofactor Using LC-MS/MS Analysis05:43

A Protein Preparation Method for the High-throughput Identification of Proteins Interacting with a Nuclear Cofactor Using LC-MS/MS Analysis

Published on: January 24, 2017

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Immunocytochemistry and Immunohistochemistry01:22

Immunocytochemistry and Immunohistochemistry

Immunocytochemistry (ICC) and immunohistochemistry (IHC) are techniques that use antibodies to check for specific proteins or antigens in a sample. The technique was first published by Albert Coons in 1941 to detect the presence of pneumococcal antigen in tissue sections from mice infected with Pneumococcus. Immunocytochemistry helps localization of proteins or antigens in individual cells like blood cells, stem cells, etc., while immunohistochemistry does the same for tissue samples.
These...